Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen
Anna Barkovskaya(Oslo University Hospital), Lina Prasmickaite(Oslo University Hospital)
Cited by 7
Related Papers
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
|Scientific Reports|2019|36